BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21304239)

  • 1. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
    Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
    Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
    Glas J; Stallhofer J; Ripke S; Wetzke M; Pfennig S; Klein W; Epplen JT; Griga T; Schiemann U; Lacher M; Koletzko S; Folwaczny M; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1737-44. PubMed ID: 19455118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of IL2/IL21 and FcgRIIa: significant association with the IL2/IL21 region in Scandinavian coeliac disease families.
    Adamovic S; Amundsen SS; Lie BA; Gudjónsdóttir AH; Ascher H; Ek J; van Heel DA; Nilsson S; Sollid LM; Torinsson Naluai A
    Genes Immun; 2008 Jun; 9(4):364-7. PubMed ID: 18418394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease.
    Márquez A; Orozco G; Martínez A; Palomino-Morales R; Fernández-Arquero M; Mendoza JL; Taxonera C; Díaz-Rubio M; Gómez-García M; Nieto A; López-Nevot MA; de la Concha EG; Martín J; Urcelay E
    Am J Gastroenterol; 2009 Aug; 104(8):1968-75. PubMed ID: 19471255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.
    Underhill JA; Donaldson PT; Doherty DG; Manabe K; Williams R
    Hepatology; 1995 Apr; 21(4):959-62. PubMed ID: 7705806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotype-based analysis of ulcerative colitis risk loci identifies both IL2 and IL21 as susceptibility genes in Han Chinese.
    Shi J; Zhou L; Zhernakova A; Qian J; Zhu F; Sun G; Zhu L; Ma X; Dijkstra G; Wijmenga C; Faber KN; Lu X; Weersma RK
    Inflamm Bowel Dis; 2011 Dec; 17(12):2472-9. PubMed ID: 21648020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.
    Bowlus CL; Karlsen TH; Broomé U; Thorsby E; Vatn M; Schrumpf E; Lie BA; Boberg KM
    J Hepatol; 2006 Nov; 45(5):704-10. PubMed ID: 16750586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
    Wiencke K; Louka AS; Spurkland A; Vatn M; Schrumpf E; Boberg KM;
    J Hepatol; 2004 Aug; 41(2):209-14. PubMed ID: 15288468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
    Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
    Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis.
    Festen EA; Goyette P; Scott R; Annese V; Zhernakova A; Lian J; Lefèbvre C; Brant SR; Cho JH; Silverberg MS; Taylor KD; de Jong DJ; Stokkers PC; Mcgovern D; Palmieri O; Achkar JP; Xavier RJ; Daly MJ; Duerr RH; Wijmenga C; Weersma RK; Rioux JD
    Gut; 2009 Jun; 58(6):799-804. PubMed ID: 19201773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9.
    Janse M; Lamberts LE; Franke L; Raychaudhuri S; Ellinghaus E; Muri Boberg K; Melum E; Folseraas T; Schrumpf E; Bergquist A; Björnsson E; Fu J; Jan Westra H; Groen HJ; Fehrmann RS; Smolonska J; van den Berg LH; Ophoff RA; Porte RJ; Weismüller TJ; Wedemeyer J; Schramm C; Sterneck M; Günther R; Braun F; Vermeire S; Henckaerts L; Wijmenga C; Ponsioen CY; Schreiber S; Karlsen TH; Franke A; Weersma RK
    Hepatology; 2011 Jun; 53(6):1977-85. PubMed ID: 21425313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
    Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance.
    Hollis-Moffatt JE; Chen-Xu M; Topless R; Dalbeth N; Gow PJ; Harrison AA; Highton J; Jones PB; Nissen M; Smith MD; van Rij A; Jones GT; Stamp LK; Merriman TR
    Arthritis Res Ther; 2010; 12(3):R116. PubMed ID: 20553587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis.
    Henckaerts L; Jaspers M; Van Steenbergen W; Vliegen L; Fevery J; Nuytten H; Roskams T; Rutgeerts P; Cassiman JJ; Vermeire S; Cuppens H
    J Hepatol; 2009 Jan; 50(1):150-7. PubMed ID: 18992954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
    Wiencke K; Spurkland A; Schrumpf E; Boberg KM
    Hepatology; 2001 Oct; 34(4 Pt 1):625-30. PubMed ID: 11584356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association analysis in primary sclerosing cholangitis.
    Karlsen TH; Franke A; Melum E; Kaser A; Hov JR; Balschun T; Lie BA; Bergquist A; Schramm C; Weismüller TJ; Gotthardt D; Rust C; Philipp EE; Fritz T; Henckaerts L; Weersma RK; Stokkers P; Ponsioen CY; Wijmenga C; Sterneck M; Nothnagel M; Hampe J; Teufel A; Runz H; Rosenstiel P; Stiehl A; Vermeire S; Beuers U; Manns MP; Schrumpf E; Boberg KM; Schreiber S
    Gastroenterology; 2010 Mar; 138(3):1102-11. PubMed ID: 19944697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.
    Yang X; Cullen SN; Li JH; Chapman RW; Jewell DP
    J Hepatol; 2004 Mar; 40(3):375-9. PubMed ID: 15123348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis.
    Daha NA; Kurreeman FA; Marques RB; Stoeken-Rijsbergen G; Verduijn W; Huizinga TW; Toes RE
    Arthritis Rheum; 2009 May; 60(5):1255-60. PubMed ID: 19404967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
    Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Lööf LA; Sandberg-Gertzén H; Almer S; Askling J; Ehlin A; Ekbom A
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):939-43. PubMed ID: 18674735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.